DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Yamane M, Kawashima K, Yamaguchi K et al.
In vitro profiling of the metabolism and drug–drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes and recombinant human CYP.
Xenobiotica 2015;
45: 230-238
We do not assume any responsibility for the contents of the web pages of other providers.